Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with clear health benefits and payer coverage, why has pump adoption been so ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Disclosures Diabetes Care. 2015;38 (4):716-722. Customer Complaints and Pump Recalls When a user returns a pump to the manufacturer, its performance status following real-life use can be evaluated.

ACTON, Mass., June 19, 2025--Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association Conference ...

The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...

Oral Presentations Friday, June 20, Session: 5:30 – 6:30 PM CT, Presentation 5:45 – 6:00 PM CT (W184A-D) 130-OR– Real-World Glycemic Outcomes in Adults with Type 2 Diabetes (T2D) Using the Omnipod 5 ...

It’s also unwelcome news for insulin pump maker Insulet, and glucose-monitor suppliers DexCom and Abbott ...

Tandem’s Control-IQ+ algorithm powers automated insulin delivery with two different tubed insulin pumps: the t:slim X2 pump and the more compact Mobi pump. Without insurance, both pumps cost $4,000, ...